XILIO THERAPEUTICS INC's ticker is and the CUSIP is 98422T100. A total of 42 filers reported holding XILIO THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $37,554 | -19.5% | 17,798 | 0.0% | 0.00% | – |
| Q2 2023 | $46,631 | -12.9% | 17,798 | +5.3% | 0.00% | – |
| Q1 2023 | $53,563 | +54.4% | 16,897 | +31.0% | 0.00% | – |
| Q4 2022 | $34,701 | -8.7% | 12,900 | 0.0% | 0.00% | – |
| Q3 2022 | $38,000 | 0.0% | 12,900 | 0.0% | 0.00% | – |
| Q2 2022 | $38,000 | -91.5% | 12,900 | -79.7% | 0.00% | – |
| Q1 2022 | $449,000 | -55.5% | 63,573 | +0.9% | 0.00% | – |
| Q4 2021 | $1,009,000 | – | 63,034 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|